Recent studies have shown that Rh2 and Rg3 inhibited migration, proliferation, invasion, and cancer-related inflammation via downregulating Wnt/β-catenin signaling in glioblastoma [32, 72]. The gene discussed is RHAG; the disease is glioblastoma.